CUV 3.92% $15.65 clinuvel pharmaceuticals limited

Shorts are trapped, page-8

  1. 14 Posts.
    lightbulb Created with Sketch. 4
    Not so sure we are in clear air. The price appreciation has been driven by the shorts .... almost like they are inviting the BB to come out and play. They pump up the price to suck in what super thin retail interest there is and drop it to pick up the stop loss victims.
    We need investor interest in CUV and that is not there. A strong announcement that the vitiligo trial is now fully recruited and some teasers on the OTC may get us some visibility.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.